Retatrutide

emerging · Fat Loss · Also known as LY3437943

Retatrutide is a triple agonist targeting GLP-1, GIP, and glucagon receptors simultaneously. Early trials show even greater weight loss than tirzepatide or semaglutide alone.

View Retatrutide studies on PubMed

For Research Purposes Only. Not Medical Advice.